Jentashapir Journal of Health Research

Published by: Kowsar

Assessment of Serum Tri-Iodothyronine (T3), Thyroxin (T4) and Thyroid-Stimulating Hormone (TSH) Levels Among Patients With Major Depressive Disorder (MDD) in Hamedan, Northwestern Iran

Seyed Mehrdad Kassaee 1 , * , Rahim Ahmadi 1 , Asghar Seif 2 and Sedigheh Molaei 3
Authors Information
1 Department of Physiology, Faculty of Basic Sciences, Hamedan Branch, Islamic Azad University, Hamedan, IR Iran
2 Department of Statistics, Faculty of Basic Sciences, Bu-Ali Sina University, Hamedan, IR Iran
3 School of Medicine, Student Research Committee, Qom University of Medical Sciences, Qom, IR Iran
Article information
  • Jentashapir Journal of Health Research: April 2016, 7 (2); e23066
  • Published Online: April 27, 2016
  • Article Type: Research Article
  • Received: August 26, 2014
  • Revised: November 26, 2015
  • Accepted: December 2, 2015
  • DOI: 10.17795/jjhr-23066

To Cite: Kassaee S M, Ahmadi R, Seif A, Molaei S. Assessment of Serum Tri-Iodothyronine (T3), Thyroxin (T4) and Thyroid-Stimulating Hormone (TSH) Levels Among Patients With Major Depressive Disorder (MDD) in Hamedan, Northwestern Iran, Jundishapur J Helath Res. 2016 ;7(2):e23066. doi: 10.17795/jjhr-23066.

Abstract
Copyright: Copyright © 2016, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O'Reilly EJ, et al. Coffee, caffeine, and risk of depression among women. Arch Intern Med. 2011; 171(17): 1571-8[DOI][PubMed]
  • 2. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. The Lancet. 2013; 382(9904): 1575-86
  • 3. Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Lee D, et al. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder. J Affect Disord. 2014; 169: 112-7[DOI][PubMed]
  • 4. Fjaellegaard K, Kvetny J, Allerup PN, Bech P, Ellervik C. Well-being and depression in individuals with subclinical hypothyroidism and thyroid autoimmunity - a general population study. Nord J Psychiatry. 2015; 69(1): 73-8[DOI][PubMed]
  • 5. Kim EY, Kim SH, Rhee SJ, Huh I, Ha K, Kim J, et al. Relationship between thyroid-stimulating hormone levels and risk of depression among the general population with normal free T4 levels. Psychoneuroendocrinology. 2015; 58: 114-9[DOI][PubMed]
  • 6. Roberts RE, Shema SJ, Kaplan GA, Strawbridge WJ. Sleep complaints and depression in an aging cohort: A prospective perspective. Am J Psychiatry. 2000; 157(1): 81-8[DOI][PubMed]
  • 7. Jackson IM. Does thyroid hormone have a role as adjunctive therapy in depression? Thyroid. 1996; 6(1): 63-7[DOI][PubMed]
  • 8. Dayan CM, Panicker V. Hypothyroidism and depression. Eur Thyroid J. 2013; 2(3): 168-79[DOI][PubMed]
  • 9. Veldhoen N, Propper CR, Helbing CC. Enabling comparative gene expression studies of thyroid hormone action through the development of a flexible real-time quantitative PCR assay for use across multiple anuran indicator and sentinel species. Aquat Toxicol. 2014; 148: 162-73[DOI][PubMed]
  • 10. Shakeri J, Jaberghaderi N, Rezaei M, Saeedi M, Naleini M, Moloodi A. Psychosocial risk factors in patients with cardio-vascular diseases in Kermanshah (2006) Psychosocial risk factors in patients with cardio-vascular diseases in Kermanshah (2006) Psychosocial risk factors in patients with cardio-vascular diseases in Kermansh. J Kermanshah Univ Med Sci. 2012; 16(3): 246-54
  • 11. Pahlavanzadeh S, Navidian A, Yazdani M. The effect of psycho-education on depression, anxiety and stress in family caregivers of patients with mental disorders. Journal of Kermanshah University of Medical Sciences (J Kermanshah Univ Med Sci). 2010; 14(3)
  • 12. Lolis MS, Goldberg DJ. Clinical Dermatology Trials 101. 2015; : 135-42
  • 13. Farinde A. The Beck Depression Inventory. The Pharma Innovation-Journal. 2013; 2(1): 56-62
  • 14. Pakseresht S, Boustani H, Azemi ME, Nilsaz J, Babapour R, Haghdust MR. Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial. Jundishapur J Nat Pharm Prod. 2012; 7(3): 106-10[PubMed]
  • 15. Hayden MJ, Brown WA, Brennan L, O'Brien PE. Validity of the Beck Depression Inventory as a screening tool for a clinical mood disorder in bariatric surgery candidates. Obes Surg. 2012; 22(11): 1666-75[DOI][PubMed]
  • 16. Ghasemi A, Zahediasl S. Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab. 2012; 10(2): 486-9[DOI][PubMed]
  • 17. Das BK, Baral N, Shyangwa PM, Toora BD, Lamsal M. Altered serum levels of thyroxine, triiodothyroinine and thyroid stimulating hormone in patients with depression. KUMJ. 2006; 5(3): 330-4
  • 18. Gold MS, Pottash AC, Mueller E3, Extein I. Grades of thyroid failure in 100 depressed and anergic psychiatric inpatients. Am J Psychiatry. 1981; 138(2): 253-5[DOI][PubMed]
  • 19. Fountoulakis KN, Iacovides A, Grammaticos P, St Kaprinis G, Bech P. Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry. 2004; 4: 6[DOI][PubMed]
  • 20. Wu EL, Chien IC, Lin CH, Chou YJ, Chou P. Increased risk of hypothyroidism and hyperthyroidism in patients with major depressive disorder: a population-based study. J Psychosom Res. 2013; 74(3): 233-7[DOI][PubMed]
  • 21. Najafi L, Malek M, Hadian A, Ebrahim Valojerdi A, Khamseh ME, Aghili R. Depressive symptoms in patients with subclinical hypothyroidism-the effect of treatment with levothyroxine: a double-blind randomized clinical trial. Endocr Res. 2015; 7(4): 1-6
  • 22. Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab. 2012; 97(7): 2256-71[DOI][PubMed]
  • 23. van de Ven AC, Muntjewerff JW, Netea-Maier RT, de Vegt F, Ross HA, Sweep FC, et al. Association between thyroid function, thyroid autoimmunity, and state and trait factors of depression. Acta Psychiatr Scand. 2012; 126(5): 377-84[DOI][PubMed]
  • 24. Budania S, Rathi M, Singh S, Yadav S, Verma N. Depression and thyroid function tests. Muller. 2015; 6(1): 54-62
  • 25. Joffe RT, Pearce EN, Hennessey JV, Ryan JJ, Stern RA. Subclinical hypothyroidism, mood, and cognition in older adults: a review. Int J Geriatr Psychiatry. 2013; 28(2): 111-8[DOI][PubMed]
  • 26. Demartini B, Masu A, Scarone S, Pontiroli AE, Gambini O. Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med. 2010; 52(4): 277-82[PubMed]
  • 27. Howland RH. Use of endocrine hormones for treating depression. J Psychosoc Nurs Ment Health Serv. 2010; 48(12): 13-6[DOI][PubMed]
  • 28. Premachandra BN, Kabir MA, Williams IK. Low T3 syndrome in psychiatric depression. J Endocrinol Invest. 2006; 29(6): 568-72[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader